Open access · CC-BY
via OpenAlex
Increased alpha-synuclein tear fluid levels in patients with Parkinson’s disease
Fabian Maass, Sebastian Rikker, Vivian Dambeck, Carmina Carelia Warth Pérez Arias, Lars Tatenhorst, Ilona Csóti, Matthias Schmitz, Inga Zerr, Andreas Leha, Mathias Bähr, Paul Lingor
Scientific Reports · 2020 · ▲ 65 citations
Abstract
The objective of the study was to estimate if altered levels of alpha-synuclein can be detected in tear fluid of patients with Parkinson's disease (PD). Therefore, tear fluid samples of 75 PD patients, 75 control subjects and 31 atypical Parkinsonian patients were collected and analyzed in triplicates using an ultra-sensitive single molecule array (SIMOA) system and applying a human alpha-synuclein immunoassay. In PD, levels of total soluble alpha-synuclein were significantly increased compared to control subjects (p = 0.03; AUC PD vs. controls 0.60). There was no difference comparing PD patients stratified by Hoehn & Yahr stages and atypical Parkinsonian syndromes stratified by tauopathies and non-PD-synucleinopathies against each other (p > 0.05). In conclusion, alpha-synuclein can be detected and quantified in tear fluid, revealing small but significant differences in total alpha-synuclein levels between PD and control subjects. Tear fluid can be collected non-invasively and risk-free, therefore presenting a promising source for further biomarker research.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1038/s41598-020-65503-1
- Canonical
- link ↗
- Fetched
- 2026-10-27 MST
Cite this
APA
Maass, F., Rikker, S., Dambeck, V., Arias, C.C.W.P., Tatenhorst, L., Csóti, I., Schmitz, M., Zerr, I., Leha, A., Bähr, M., & Lingor, P. (2020). Increased alpha-synuclein tear fluid levels in patients with Parkinson’s disease. <em>Scientific Reports</em>. https://doi.org/10.1038/s41598-020-65503-1
Vancouver
Maass F, Rikker S, Dambeck V, Arias CCWP, Tatenhorst L, Csóti I, et al. Increased alpha-synuclein tear fluid levels in patients with Parkinson’s disease. Scientific Reports. 2020. doi:10.1038/s41598-020-65503-1.
BibTeX
@article{fabian2020Increa,
title = {Increased alpha-synuclein tear fluid levels in patients with Parkinson’s disease},
author = {Fabian Maass and Sebastian Rikker and Vivian Dambeck and Carmina Carelia Warth Pérez Arias and Lars Tatenhorst and Ilona Csóti and Matthias Schmitz and Inga Zerr and Andreas Leha and Mathias Bähr and Paul Lingor},
journal = {Scientific Reports},
year = {2020},
doi = {10.1038/s41598-020-65503-1},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Parkinson s Disease 2020
Preprint · OA
Alpha-Synuclein Protofibrils in Cerebrospinal Fluid: A Potential Biomarker for Parkinson's Disease
The Egyptian Journal of Neurology Psychiatry and Neurosurgery 2020
Open access · CC-BY
Salivary alpha-synuclein (total and oligomeric form): potential biomarkers in Parkinson’s disease
London North West Healthcare NHS Trust 2022
Open access · US-GOV
Use of Perioperative Testosterone Replacement Therapy (TRT) in Sarcopenic Male Colorectal Cancer Patients - A Single Arm Open Label Feasibility Study
Global Medical & Health Communication (GMHC) 2022
Open access · CC-BY
Association between Serum Alpha-Synuclein Levels and Parkinson's Disease Stage
European Journal of Neurology 2025
Open access · CC-BY
Cerebrospinal Fluid Phosphorylated Alpha‐Synuclein in Newly Diagnosed Parkinson's Disease
Novartis Pharmaceuticals 2023
Open access · US-GOV